Partner Craig Bleifer is speaking on the panel “Mastering Mergers & Acquisitions Compliance – Examining Due Diligence Strategies” at the Pharmaceutical Compliance Congress – West on September 4.
The panel will discuss how to strategically prepare your compliance program for rigorous due diligence, enhancing your company’s valuation and attractiveness; the critical compliance due diligence items that provide essential insights into target companies, minimizing risk and ensuring successful integration; and best practices for building robust, acquisition-ready compliance programs that strengthen operational integrity and drive long-term value.
McGuireWoods is also a proud sponsor of the conference.
For additional details and registration, please visit the event website.